News
India implement a new policy to provide million with free medicine, but it’s a decision that will hit global pharmaceutical companies, who research and develop drugs for emerging markets. A policy has been put in place in India to provide hundreds of millions with free medicine. While this decision could change the lives of…
AstraZeneca and Bristol-Myers Squibb further expand their ongoing diabetes alliance, following the completion of Bristol-Myers Squibb’s acquisition of Amylin Pharmaceuticals. Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition…
The U.S. Supreme Court has voted in favour of President Obama’s healthcare reform, dubbed Obamacare, to provide Americans with affordable medical coverage. Healthcare is a highly debatable subject in the United States, so when Obama signed The Patient Protection and Affordable Care Act (ACA) into law in March 2010…
A new report shows that the emerging markets in Brazil, Russia, India and China, are now responsible for between 20 and 30 % of pharma companies’ profits. The emerging markets of Brazil, Russia, India and China (BRIC) are now responsible for 20 – 30% of pharmaceutical…
A new partnership, of pharma companies and research institutions, has been launched to speed the discovery of new, more effective, drugs for patients with tuberculosis. The TB Drug Accelerator, a partnership of seven pharmaceutical companies and four research institutions, has been launched…
Daniel Ghinn’s new e-journal and hardback book, Pathways to Engagement for Healthcare Organizations, launches today, offering plenty of tips and tricks for healthcare marketers and communicators in order to create successful online patient engagement campaigns. Digital engagement within healthcare began to rapidly take off in early 2009 – now, technology is advancing faster than ever…
Shire’s share price drops as U.S. regulators approve a cut-price version of its ADHD drug, Adderall XR, despite an appeal against the move from the biopharmaceutical company. Shire’s shares have suffered a near-12pc slide in price after U.S. regulators ruled against the biopharmaceutical company in a battle…
Danish pharma company, Novo Nordisk, announced its decision to initiate global phase III clinical trials of developmental type 2 diabetes treatment, semaglutide, in early 2013. Novo Nordisk has announced its decision to initiate global phase III clinical trials for semaglutide, a human Glucagon-Like Peptide-1 (GLP-1) analogue…
The US FDA’s ODAC has awarded a positive vote to Onyx Pharma’ Kyprolis, for use in multiple myeloma across a variety of treatment lines, and the NDA has been accelerated forward for a final decision in July. Onyx Pharmaceuticals, Inc. has announced that the US FDA’s Oncologic Drug Advisory Committee (ODAC) has given a positive vote towards Kyprolis…
